MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)
$0.1 -0.0106 (-9.5841%)
Analysed MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) News Sources
Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204
08-06-2026
yahoo.com
New Autism Research to be Presented at European Purine Scientific Meeting
26-06-2026
yahoo.com
Marvel Biosciences Expands Private Placement to Quebec
19-08-2026
yahoo.com
Marvel Biosciences Announces Extension to Closing Date of Private Placement
09-09-2026
yahoo.com
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
16-04-2026
yahoo.com
Marvel Biosciences Announces Closing of Convertible Debenture Offering
17-04-2026
yahoo.com
Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit
23-04-2026
yahoo.com
Marvel Biosciences Announces Grant of Deferred Share Units
20-05-2026
yahoo.com
Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X
05-08-2026
yahoo.com
What is the current price of MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)?
The current price of MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) is $0.1.
MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) since the previous trading day is $-0.0106.
MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) since the previous trading day is -9.5841%.
What is the most recent average sentiment score for MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)?
The most recent average sentiment score for MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) is 59 out of 100.
What is the most recent average sentiment for MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)?
The most recent sentiment for MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) is .
SEC-8K** Filing Available For MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.